ANDA 77530, held by Ivax Pharms. Valsartan.
As of Nov 14, 2026, ANDA 77530 (Valsartan), held by Ivax Pharms, was first approved by FDA on Jan 4, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 4, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
